Literature DB >> 15498879

Androgenic induction of growth and differentiation in the rodent uterus involves the modulation of estrogen-regulated genetic pathways.

Pascale V Nantermet1, Patricia Masarachia, Michael A Gentile, Brenda Pennypacker, Jian Xu, Daniel Holder, David Gerhold, Dwight Towler, Azriel Schmidt, Donald B Kimmel, Leonard P Freedman, Shun-ichi Harada, William J Ray.   

Abstract

The androgen receptor (AR) is expressed in the uterus; however, the role of AR in female reproductive physiology is poorly understood. Here we examined the effects of androgens on uterine growth and gene expression in adult ovariectomized rats. Nonaromatizable AR-selective agonists potently stimulate hypertrophy and induce significant myometrial expansion distinct from that induced by 17beta-estradiol (E2). In the endometrium, androgens only modestly increase epithelial cell height and antagonize the trophic effects of E2. To identify underlying mechanisms, global changes in RNA levels 24 h after stimulation with E2 and 5alpha-dihydrotestosterone (DHT) were compared. A total of 491 genes were differentially expressed after E2 treatment, including key regulators of tissue remodeling, cell signaling, metabolism, and gene expression. Of the 164 transcripts regulated by DHT, 86% were also affected by E2, including trophic genes like IGF-I and epithelial secretory genes such as uterocalin. In estrogen receptor (ER)alpha knockout mice, DHT cannot induce uterine growth, suggesting a key role for ERalpha. However, DHT appears not to activate ERalpha directly because DHT induction of IGF-I is blocked by the AR antagonist bicalutamide, and multiple genes regulated directly by ERalpha were not induced by DHT. The similarity between estrogens and androgens instead could reflect general trophic signaling in reproductive tissues because 93 of the 503 genes regulated in the uterus are similarly affected during prostate growth. Thus androgens regulate the trophic environment and architecture of the rodent uterus via a gene expression program that is overlapping but distinct from the estrogen response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498879     DOI: 10.1210/en.2004-1132

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

Review 1.  Targeting the androgen receptor in prostate and breast cancer: several new agents in development.

Authors:  Tracy Proverbs-Singh; Jarett L Feldman; Michael J Morris; Karen A Autio; Tiffany A Traina
Journal:  Endocr Relat Cancer       Date:  2015-02-26       Impact factor: 5.678

2.  Tissue-selective regulation of androgen-responsive genes.

Authors:  Maya Otto-Duessel; Miaoling He; Jeremy O Jones
Journal:  Endocr Res       Date:  2012-05-16       Impact factor: 1.720

3.  Discovery of the selective androgen receptor modulator MK-0773 using a rational development strategy based on differential transcriptional requirements for androgenic anabolism versus reproductive physiology.

Authors:  Azriel Schmidt; Donald B Kimmel; Chang Bai; Angela Scafonas; Sujane Rutledge; Robert L Vogel; Sheila McElwee-Witmer; Fang Chen; Pascale V Nantermet; Viera Kasparcova; Chih-Tai Leu; Hai-Zhuan Zhang; Mark E Duggan; Michael A Gentile; Paul Hodor; Brenda Pennypacker; Patricia Masarachia; Evan E Opas; Sharon A Adamski; Tara E Cusick; Jiabing Wang; Helen J Mitchell; Yuntae Kim; Thomayant Prueksaritanont; James J Perkins; Robert S Meissner; George D Hartman; Leonard P Freedman; Shun-ichi Harada; William J Ray
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

4.  Stem cell activation in adults can reverse detrimental changes in body composition to reduce fat and increase lean mass in both sexes.

Authors:  Kristine M Wiren; Joel G Hashimoto; Xiao-Wei Zhang
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

5.  High serum androstenedione levels correlate with impaired memory in the surgically menopausal rat: a replication and new findings.

Authors:  Bryan W Camp; Julia E Gerson; Candy Wing S Tsang; Stephanie R Villa; Jazmin I Acosta; B Blair Braden; Ann N Hoffman; Cheryl D Conrad; Heather A Bimonte-Nelson
Journal:  Eur J Neurosci       Date:  2012-07-03       Impact factor: 3.386

6.  Enhanced evaluation of selective androgen receptor modulators in vivo.

Authors:  M Otto-Duessel; M He; T W Adamson; J O Jones
Journal:  Andrology       Date:  2012-08-28       Impact factor: 3.842

7.  Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function.

Authors:  K A Walters; K J McTavish; M G Seneviratne; M Jimenez; A C McMahon; C M Allan; L A Salamonsen; D J Handelsman
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

8.  Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver.

Authors:  Vasanthi R Sunil; Kinal J Patel; Marit Nilsen-Hamilton; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2007-03-30       Impact factor: 3.362

9.  Identification of anabolic selective androgen receptor modulators with reduced activities in reproductive tissues and sebaceous glands.

Authors:  Azriel Schmidt; Shun-Ichi Harada; Donald B Kimmel; Chang Bai; Fang Chen; Su Jane Rutledge; Robert L Vogel; Angela Scafonas; Michael A Gentile; Pascale V Nantermet; Sheila McElwee-Witmer; Brenda Pennypacker; Patricia Masarachia; Soumya P Sahoo; Yuntae Kim; Robert S Meissner; George D Hartman; Mark E Duggan; Gideon A Rodan; Dwight A Towler; William J Ray
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

10.  Genetic variation in the androgen receptor gene and endometrial cancer risk.

Authors:  Hannah P Yang; Montserrat Garcia-Closas; James V Lacey; Louise A Brinton; Jolanta Lissowska; Beta Peplonska; Stephen Chanock; Mia M Gaudet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.